PA-PMI
14.9.2020 15:02:33 CEST | Business Wire | Press release
Project Management Institute (PMI), the world's leading association for the project management profession, is shining a light on the talents and ideas of the project community during TED@PMI: Action + Impact , a virtual event on 25-26 September 2020. Open to the public, this free event will celebrate a community of doers and the vision, inspiration and mesmerizing awe of turning big ideas into action.
The TED@PMI Talks were sourced directly from the PMI community. More than 600,000 members and 500 employees, as well as more than 330,000 certification holders in China had the chance to submit their ideas. Through a multi-round process, a team of TED coaches, including TED@PMI Curator Sally Kohn, vetted the entries to find the most compelling stories. From the applicant pool, 12 individuals were selected to go through the TED Talk speaker process, where coaches provide one-on-one storytelling guidance, talk development and public speaking training to sharpen and hone ideas and talks.
During the event, the speakers will take the TED@PMI mainstage across two days, but the event is not just about the Talks. Pre-, during and post-event activities make it possible to build community through experience. Start the event with a total body workout or guided meditation with fellow attendees. Before the TED@PMI mainstage session, learn how to brew the perfect cappuccino and craft the best cocktail to enjoy during the event. Unwind after the mainstage session during the virtual DJ dance parties or by diving deeper into the speakers’ stories during speaker panel discussions. Stay connected with other attendees by creating and exchanging virtual business cards.
“These individuals are not just dedicated to telling their story, they’re dedicated to taking action and making an impact,” said Sunil Prashara, President and CEO of PMI. “It’s people like this - those not afraid to turn an idea into reality - who solve our world’s biggest problems.”
The 12 TED@PMI speakers hail from around the world, representing PMI’s global footprint. From trauma and healing, to communication and community, to project management and social change, these speakers tell their boldest and most inspiring stories.
- Chiwuike Amaechi (Lagos, Nigeria): Storytelling as tradition and transformation that connects us all
- Khulan Batkhuyag (Ulaanbaatar, Mongolia): Permanent life-lessons from the nomadic life of Mongolians
- Wale Elegbede (Rochester, N.Y., U.S.): Stop seeing discrimination as “their” problem and see it as “our problem” — all of us
- Kristin Jones (Springfield, Pa., U.S.): How to talk with your kids about sexual assault, without spreading shame
- Betsy Kauffman (Charlotte, N.C., U.S.): My son with autism is really blunt — and we should all be more like him
- Dinae Knox (Chicago, Ill., U.S.): How to turn life’s depleted soil into rich compost
- YeYoon Kim (Singapore): What kindergarteners taught me about the gift of asking for help
- Kathy Mendias (Bonita, Calif., U.S.): The case for crying — a lot
- Billy Samuel Mwape (Lusaka, Zambia): What if we saw kids with special needs not as problems, but projects
- Danielle Torley (Destin, Fla., U.S.): One woman’s journey from losing a family member in a fire to… becoming a fire dancer?!?
- Mounina Tounkara (Nice, France): The immigrant experience of racism and confronting outsider/insider bias
- Jess Woods (Tucson, Ariz., U.S.): Avoiding the prickly cactuses of life — literally and figuratively
The TED@PMI partnership is all about identifying thought-leaders and unearthing the best ideas from the project management community. Every year, the TED Institute works with a group of carefully selected organizations like PMI to identify their best inventors, connectors, and creators.
To register for free today or to learn more about the speakers, visit: TED.PMI.org .
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org
, www.projectmanagement.com
, www.facebook.com/PMInstitute
and on Twitter @PMInstitute
.
About TED
TED is a nonprofit organization devoted to Ideas Worth Spreading, often in the form of short talks delivered by leading thinkers and doers. Many of these talks are given at TED conferences, intimate TED Salons, and thousands of independently organized TEDx events around the world. Videos of these talks are made available, free, on TED.com
and other platforms. Audio versions of TED Talks are published to TED Talks Daily
, available on all podcast platforms.
TED's open and free initiatives for spreading ideas include TED.com , where new TED Talk videos are posted daily; TEDx , which licenses thousands of individuals and groups to host local, self-organized TED-style events around the world; the TED Fellows program, which selects innovators from around the globe to amplify the impact of their remarkable projects and activities; The Audacious Project , which surfaces and funds critical ideas that have the potential to impact millions of lives; TED Translate , which crowdsources the subtitling of TED Talks so that big ideas can spread across languages and borders; and the educational initiative TED-Ed . TED also has a growing library of original podcasts, including The TED Interview with Chris Anderson, WorkLife with Adam Grant , Pindrop and TEDxSHORTS .
Follow TED on Twitter , Facebook , Instagram and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005509/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
